DK0539509T3 - 4-Alkylimidazolderivater - Google Patents

4-Alkylimidazolderivater

Info

Publication number
DK0539509T3
DK0539509T3 DK91914167.1T DK91914167T DK0539509T3 DK 0539509 T3 DK0539509 T3 DK 0539509T3 DK 91914167 T DK91914167 T DK 91914167T DK 0539509 T3 DK0539509 T3 DK 0539509T3
Authority
DK
Denmark
Prior art keywords
alkylimidazole derivatives
alkylimidazole
derivatives
angiotensin
potency
Prior art date
Application number
DK91914167.1T
Other languages
Danish (da)
English (en)
Inventor
David John Carini
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Application granted granted Critical
Publication of DK0539509T3 publication Critical patent/DK0539509T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91914167.1T 1990-07-13 1991-07-15 4-Alkylimidazolderivater DK0539509T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55263790A 1990-07-13 1990-07-13
US07/650,258 US5137902A (en) 1990-07-13 1991-02-04 4-alkylimidazole derivatives and anti-hypertensive use thereof

Publications (1)

Publication Number Publication Date
DK0539509T3 true DK0539509T3 (da) 1995-07-03

Family

ID=27070086

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91914167.1T DK0539509T3 (da) 1990-07-13 1991-07-15 4-Alkylimidazolderivater

Country Status (23)

Country Link
US (1) US5137902A (cs)
EP (1) EP0539509B1 (cs)
JP (1) JP2550455B2 (cs)
KR (1) KR0162669B1 (cs)
AT (1) ATE121087T1 (cs)
AU (1) AU639400B2 (cs)
BG (1) BG61341B1 (cs)
CA (1) CA2087274C (cs)
CZ (1) CZ280018B6 (cs)
DE (1) DE69108913T2 (cs)
DK (1) DK0539509T3 (cs)
ES (1) ES2071325T3 (cs)
FI (1) FI102752B (cs)
HU (2) HUT63411A (cs)
IE (1) IE69849B1 (cs)
IL (1) IL98794A (cs)
MY (1) MY140243A (cs)
NO (1) NO303015B1 (cs)
NZ (1) NZ238920A (cs)
PL (1) PL168311B1 (cs)
RO (1) RO111270B1 (cs)
SK (1) SK279326B6 (cs)
WO (1) WO1992000977A2 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate
US5250558A (en) * 1992-01-28 1993-10-05 Merck & Co., Inc. Substituted triazolinones, triazolinethiones, and triazolinimines as neurotensin antagonists used to treat psychosis
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
GB9218449D0 (en) 1992-08-29 1992-10-14 Boots Co Plc Therapeutic agents
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
US5338740A (en) * 1993-07-13 1994-08-16 Pfizer Inc. Angiotensin II receptor antagonists
SE9903028D0 (sv) 1999-08-27 1999-08-27 Astra Ab New use
AU2001267404A1 (en) * 2000-05-04 2001-11-12 Ipf Pharmaceuticals Gmbh Novel compounds for the treatment of inflammatory and cardiovascular diseases
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US20070054948A1 (en) * 2004-09-02 2007-03-08 Lilach Hedvati Purification of olmesartan medoxomil
KR20090102883A (ko) * 2004-09-02 2009-09-30 테바 파마슈티컬 인더스트리즈 리미티드 올메살탄 메독소밀의 정제
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US5015651A (en) * 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
SG52709A1 (en) * 1989-06-30 1998-09-28 Du Pont Substituted imidazoles
JP2568315B2 (ja) * 1989-06-30 1997-01-08 イー・アイ・デュポン・ドゥ・ヌムール・アンド・カンパニー 縮合環アリール置換イミダゾール
DE4132633A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Cyclisch substituierte imidazolyl-propensaeurederivate

Also Published As

Publication number Publication date
KR0162669B1 (ko) 1998-12-01
JPH05508415A (ja) 1993-11-25
IE69849B1 (en) 1996-10-02
PL297616A1 (cs) 1992-07-13
JP2550455B2 (ja) 1996-11-06
IE912438A1 (en) 1992-01-15
CZ280018B6 (cs) 1995-09-13
SK391292A3 (en) 1993-07-07
AU639400B2 (en) 1993-07-22
BG97438A (bg) 1994-03-24
HU223530B1 (hu) 2004-08-30
EP0539509A1 (en) 1993-05-05
MY140243A (en) 2009-12-31
NO303015B1 (no) 1998-05-18
DE69108913T2 (de) 1995-08-24
IL98794A (en) 1995-11-27
FI102752B1 (fi) 1999-02-15
NO930088D0 (no) 1993-01-11
RO111270B1 (ro) 1996-08-30
FI102752B (fi) 1999-02-15
FI930109A0 (fi) 1993-01-12
ES2071325T3 (es) 1995-06-16
FI930109L (fi) 1993-01-12
US5137902A (en) 1992-08-11
HU9204058D0 (en) 1993-03-29
CZ391292A3 (en) 1993-12-15
NZ238920A (en) 1993-07-27
NO930088L (no) 1993-01-11
EP0539509B1 (en) 1995-04-12
ATE121087T1 (de) 1995-04-15
BG61341B1 (en) 1997-06-30
HUT63411A (en) 1993-08-30
CA2087274C (en) 2002-02-19
WO1992000977A3 (en) 1992-02-20
WO1992000977A2 (en) 1992-01-23
PL168311B1 (pl) 1996-02-29
DE69108913D1 (de) 1995-05-18
AU8311691A (en) 1992-02-04
SK279326B6 (sk) 1998-10-07
IL98794A0 (en) 1992-07-15
CA2087274A1 (en) 1992-01-14

Similar Documents

Publication Publication Date Title
DE69108913D1 (de) 4-alkylimidazolderivate.
DE69620443D1 (de) Naphthyl substituierte benzimidazolderivate als antikoagulantien
LU91122I2 (fr) Efalizumab et ses dérivés pharmaceutiquement acceptables (raptiva).
LU91205I2 (fr) Ciclesonide et ses dérivés pharmaceutiquement acceptables (alvesco)
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
DE69717827D1 (de) Benzofuran-4-carboxamide
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
ES2052897T3 (es) Nucleosidos didesoxidideshidrocarbociclicos.
NO952743D0 (no) Ny benzotiadiazinforbindelse, dens fremstilling og farmasöytiske preparater
DK199587D0 (da) Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner
NO20033184D0 (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
DE69100517D1 (de) Polyethyleneiminphosphonatderivate als Dispergiermittel enthaltende Zementzusammensetzungen.
FI890185A0 (fi) Foerfarande foer framstaellning av 1-alkyl-5-nitroimidazoler.
DK199487D0 (da) Heterocykliske derivater af n'-substituerede-n,n'-diacylhydraziner
EE02942B1 (et) Metüülpiperasinoasepiini derivaadid, nende valmistamine ja kasutamine
FI912963A0 (fi) Hjaernverksamheten oekande pyrimidinylderivat.
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
LU88789I2 (fr) Mésylate de tirilazad et ses dérivés pharmaceutiquement acceptables (Freedox (R))
FI914087A0 (fi) Foerfarande och anordning foer detektering av verktygshaverier i skaerande bearbetning.
FI970397A0 (fi) Substituoituja 1,4-dihydroksylopent(b)indol-3(2H)-onijohdannaisia
DK336088A (da) Antitumormiddel opnaaet ved mikrobiel stereoselektiv reduktion af 4'-deoxy-4'-ioddoxorubicin
IT1255093B (it) Derivati imidazolidinonici come agenti nootropici
GR1001386B (el) Ετεροκυκλικές ενώσεις.